Selfishness was also a problem when the world was developing vaccines for swine flu and bird flu.
L’expertise universitaire, l’exigence journalistique
Articles sur Coronavirus
Affichage de 1421 à 1440 de 5486 articles
The results indicate that the vaccine efficacy in the UK was 89% for individuals who received at least two doses of vaccine. In South Africa, the vaccine efficacy was 60% in people without HIV.
CC BY-NC-ND17,6 Mo (download)
The Novavax vaccine is the first that provides objective scientific evidence that it can protect people against the variant virus circulating in South Africa.
The COVID-19 pandemic has seen a rise in digital localism — consumers using online local sites to buy and supply goods. Do platforms born during COVID-19 have a chance of survival?
The coronavirus is evolving, but which path it will take is far from certain.
Palestinian territories are impoverished and densely populated – ripe for the spread of coronavirus. Israel may have a practical as well as moral obligation to extend its vaccine program to them.
The more President Mnangagwa’s government fails to engage democratically with its own citizens, the more it will negate any prospect of re-engagement with the West.
By 2030, the WHO projects a worldwide workforce shortfall of about 18 million health-care workers, with potentially deadly consequences for patients, economies and our communities.
Older adults who are caregivers to someone with a health condition or disability report severe and unrelenting levels of stress and isolation during COVID-19 due to pandemic-related protocols.
The COVID-19 pandemic shone a light on how non-profit organizations operate and how they’re funded. Is it enough to boost non-profit sector capacity to address social inequities post-pandemic?
Our lives consist of a complex and dense web of interactions that ultimately make physical and social distancing attempts impossible. And this has always been the case in human society.
Scott Morrison on Monday will announce a $1.9 billion initial investment in the massive vaccine rollout which is due to start in late February.
Tensions run high as EU vaccine deliveries fall behind schedule, while new vaccines are being created to handle mutant viral strains.
The vaccine is still very likely to be protective in over-65s, even if efficacy in this age group is unknown.
On the face of it, it seems like a good idea.
If conspiracy theories are going mainstream, we have to start mainstreaming a response.
Theories that antibodies affect the placenta are completely unfounded.
Is it time for some scientists to turn back to pre-COVID-19 research?
An expert in olfaction explains the effects of long-term smell loss, the subtle role the sense plays in our lives and resources for those affected.
Results from individual studies are very precise, and not always the best grounds for making policy decisions.
Les contributeurs les plus fréquents
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Senior Research Fellow in Global Health, University of Southampton
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Medicine, University of East Anglia
-
Associate Professor, Director Cabrini Monash University Department of Nursing Research, Monash University
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Professor of Public Health, University of Sheffield
-
Senior Lecturer in Mathematical Biology, University of Bath
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Professor of Medicine, University of Virginia
